Cipla | CIPLA - Debt

Stock Price
1,202.60
Daily Change
1.70 0.14%
Monthly
-9.24%
Yearly
-16.05%
Q2 Forecast
1,166.41

Cipla reported INR4.38B in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Arca Biopharma USD 0 0 Mar/2025
aTyr Pharma USD 1.84M 8K Sep/2025
Bio Path USD 261K 261K Mar/2025
Brainstorm Cell Therapeutics USD 1.2M 1.2M Mar/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 4.38B 231.9M Mar/2025
Dr.Reddys Laboratories INR 67.73B 9.19B Dec/2025
Esperion Therapeutics USD 262.92M 1.76M Sep/2024
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 0 Sep/2024
Nektar Therapeutics USD 0 0 Jun/2022
Sangamo BioSciences USD 0 0 Jun/2022
Sun Pharmaceuticals INR 23.62B 2.1B Mar/2025
TherapeuticsMD USD 93.6M 2.82M Sep/2022
UPL INR 250.99B 81.18B Mar/2025